ReviewBiologics : targets & therapy2026

Teclistamab for Relapsed or Refractory Multiple Myeloma: A Review of Efficacy, Safety, Resistance Mechanisms and Future Directions.

Bénédicte Piron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.